Lewis H. Titterton Jr., Director at Anixa Biosciences Inc (ANIX), bought 49,036 shares at $2.69 ($132K) on 2026-09-23, disclosed to the SEC on 2026-09-25.
Open-market purchase of $132k ANIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ANIX | BUY | 2026-07-16 | $9K | — | Filing → |
| ANIX | BUY | 2026-06-17 | $7K | — | Filing → |
| PRKR | BUY | 2025-11-18 | $2.0M | — | Filing → |